Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Adrenocortical Carcinoma × Sorafenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 121 Liver Neoplasms 38 Leukemia, Myeloid, Acute 32 Carcinoma, Renal Cell 32 Neoplasm Metastasis 24 Breast Neoplasms 23 Carcinoma, Non-Small-Cell Lung 20 Kidney Neoplasms 16 Pancreatic Neoplasms 12 Neoplasms 12 Prostatic Neoplasms 11 Lung Neoplasms 11 Sarcoma 9 Recurrence 9 Melanoma 9 Myelodysplastic Syndromes 8 Colorectal Neoplasms 8 Brain Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia 6 Glioblastoma 6 Urinary Bladder Neoplasms 5 Multiple Myeloma 5 Leukemia, Myelomonocytic, Chronic 5 Thyroid Neoplasms 4 Stomach Neoplasms 4 Ovarian Neoplasms 4 Liver Diseases 4 Adenocarcinoma of Lung 4 Adenocarcinoma 4

Interventions

Mitotane 7 Cisplatin 6 pembrolizumab 4 Etoposide 3 Doxorubicin 3 camrelizumab 2 apatinib 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Cytoreduction Surgical Procedures 2 sodium thiosulfate 1 iodophenyl metomidate 1 fludarabine phosphate 1 dostarlimab 1 cemiplimab 1 cabozantinib 1 cabazitaxel 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Suramin 1 Streptozocin 1 Sorafenib 1 Radiation 1 Paclitaxel 1 Observation 1 Nivolumab 1 Megestrol Acetate 1 Lymph Node Excision 1 Ipilimumab 1 Interleukin-13 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00786110 2009-02-24

PAXO

University of Turin, Italy

Phase 2 Unknown

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡